Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)
Publication date
2019-10-01
Authors
Cejas, Paloma
Drier, Yotam
Dreijerink, Koen M A
Brosens, Lodewijk A
Deshpande, Vikram
Epstein, Charles B
Conemans, Elfi B
Morsink, Folkert H M
Graham, Mindy K
Valk, Gerlof D.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Keywords
Taverne, General Biochemistry,Genetics and Molecular Biology, Published Erratum
Citation
Cejas, P, Drier, Y, Dreijerink, K M A, Brosens, L A A, Deshpande, V, Epstein, C B, Conemans, E B, Morsink, F H M, Graham, M K, Valk, G D, Vriens, M R, Castillo, C F-D, Ferrone, C R, Adar, T, Bowden, M, Whitton, H J, Da Silva, A, Font-Tello, A, Long, H W, Gaskell, E, Shoresh, N, Heaphy, C M, Sicinska, E, Kulke, M H, Chung, D C, Bernstein, B E & Shivdasani, R A 2019, 'Publisher Correction : Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)', Nature Medicine, vol. 25, no. 10, pp. 1627. https://doi.org/10.1038/s41591-019-0573-5